The evolution of drug resistance interpretation algorithms: ANRS, REGA and extension of resistance analysis to HIV-1 group O and HIV-2. - Wikidata - awgldk - TriplyDB

The evolution of drug resistance interpretation algorithms: ANRS, REGA and extension of resistance analysis to HIV-1 group O and HIV-2.

The evolution of drug resistance interpretation algorithms: ANRS, REGA and extension of resistance analysis to HIV-1 group O and HIV-2.

http://www.wikidata.org/entity/Q37979703

about

How bioinformatics influences health informatics: usage of biomolecular sequences, expression profiles and automated microscopic image analyses for clinical needs and public health HIV-1 Genetic Variability and Clinical Implications HIV-1 genetic variation and drug resistance development.

P2860

Q28649612-C7C9F48F-FE6C-4E70-B5BD-ADFF65BB8657 Q30352010-1942AFEC-BD35-41B6-89E9-CDF1433A7808 Q30354857-F6820F8C-F08D-480B-AB47-713958CDDBF2

P2860

The evolution of drug resistance interpretation algorithms: ANRS, REGA and extension of resistance analysis to HIV-1 group O and HIV-2.

http://www.wikidata.org/entity/Q37979703

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The evolution of drug resistan ...... is to HIV-1 group O and HIV-2.

@en

The evolution of drug resistan ...... is to HIV-1 group O and HIV-2.

@nl

type

label

The evolution of drug resistan ...... is to HIV-1 group O and HIV-2.

@en

The evolution of drug resistan ...... is to HIV-1 group O and HIV-2.

@nl

prefLabel

The evolution of drug resistan ...... is to HIV-1 group O and HIV-2.

@en

The evolution of drug resistan ...... is to HIV-1 group O and HIV-2.

@nl

P1433

Q37979703-2893EE81-4090-4881-AA2D-0A3860D84717

P1476

Q37979703-8E991F8E-B6CA-44CD-B4B6-DA2FDFFE5572

P2093

Q37979703-005ED5BA-7E20-4AB7-9FA9-619BED823EFB

Q37979703-ADD56D93-F44D-4A8C-97C1-8BF4137A6289

P2860

Q37979703-00D34823-695E-4FF5-8209-2FD50E2FCCB3

Q37979703-069590BE-DFF4-405C-8E4F-8658A4FA4A93

Q37979703-0DDC8A39-9393-4D03-98C0-DDC2DF390826

Q37979703-10E3AD7F-B3E9-4749-9BE4-CBB02F7390A6

Q37979703-30C1AFA8-B137-467B-8019-92789145DAD6

Q37979703-47D2CF39-A491-4C55-B41C-6FD1C21213AB

Q37979703-51167A3A-DAB5-44D9-B9C3-502344E42F96

Q37979703-61FD13EA-1C64-4EA5-9FD8-8D528FB296D6

Q37979703-6A8352F8-C305-4226-8933-13F88AA2C9F9

Q37979703-6B44F91B-1DCC-459B-89D0-61670CD30A43

P304

Q37979703-3DB245AF-B386-46DE-81DA-1FC069E0B0D0

P31

Q37979703-257DDD5F-42C3-4D7D-84A0-709D64261E8E

P356

Q37979703-3D17C33B-BA7E-41DA-8931-ACDFFFC22E7C

P433

Q37979703-435FDBBD-4228-4EF6-BAA0-B38739F0B6FC

P478

Q37979703-944F1640-81AE-46D1-845E-AB1C251F1F1E

P577

Q37979703-18F3673D-871F-42D0-B322-8C07A971A810

P698

Q37979703-50D038CE-BCE0-4350-ADC0-951E98A1CD01

P356

P1433

P1476

The evolution of drug resistan ...... is to HIV-1 group O and HIV-2.

@en

P2093

Josef Eberle

http://www.w3.org/2001/XMLSchema#string

Lutz Gürtler

http://www.w3.org/2001/XMLSchema#string

P2860

Boceprevir for previously treated chronic HCV genotype 1 infection

Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure.

Geno2pheno[454]: a Web server for the prediction of HIV-1 coreceptor usage from next-generation sequencing data.

Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.

Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients

Predictive value of HIV-1 genotypic resistance test interpretation algorithms.

Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

Antiretroviral drug resistance in human immunodeficiency virus type 2.

P304

128-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000332009

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22286882

http://www.w3.org/2001/XMLSchema#string